StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Insider TradingJul 23, 2026, 07:01 AM

OKYO Pharma CEO Buys 15,000 Shares at $1.54 Each

AI Summary

OKYO Pharma Ltd announced that its Chief Executive Officer, Robert J. Dempsey, purchased 15,000 of the company's ordinary shares. The shares were acquired on NASDAQ at a price of $1.54 each, signaling management's confidence in the company's prospects.

Key Highlights

  • OKYO Pharma CEO Robert J. Dempsey purchased 15,000 ordinary shares.
  • Shares were acquired on NASDAQ at a price of $1.54 per share.